DEF 14AThe Ballot
Oruka Therapeutics, Inc. files DEF 14A
Filed Dec 19, 2023 · 2y ago · Accession 0000950170-23-071494
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- DEF 14A
- Filing date
- Dec 19, 2023
- Report date
- Jan 30, 2024
- Document
- abio-20231213.htm
- Size
- 3.7 MB